Pharmaceutical Companies set to supply HIV drugs

Addis Ababa- Ethiopia (PANA) -- Three Ethiopian pharmaceutical companies have submitted documents for the importation of different life-prolonging drugs for people living with HIV/AIDS, an official statement said.
The Health Ministry, which revealed the development through its pharmaceuticals Administration and Control Department, said 17 types of medicine have been approved.
An official in the Department said Tuesday that Almeta Impex, Amba pharmaceuticals Plc and Eyassu Drug and Medical Equipment Importer and distributor, have submitted the papers required by the Ministry.
Some drugs in circulation outside the country are believed to be capable of prolonging the lives of HIV/AIDS patients by between 15 and 20 years through continuous therapeutic treatment.
Mulu Solomon, Deputy General Manager of Almeta Impex, said her company has proposed to import four of the 17 medicines recommended by the Ministry.
The drugs are to be imported from UK-based company, Glaxo-Smith Kline.
She, however, suggests that "government and international organisations should consider subsidising the drugs," saying they should be exempt from tax duties.
Some three million of Ethiopia's estimated 65 million population, are said to be suffering from HIV/AIDS.

08 may 2001 12:41:00

xhtml CSS